STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$88,435
-16.0%
81,884
+0.3%
0.00%
Q2 2023$105,269
-2.3%
81,6040.0%0.00%
Q1 2023$107,717
-12.0%
81,6040.0%0.00%
Q4 2022$122,406
+27.5%
81,6040.0%0.00%
Q3 2022$96,000
+4.3%
81,6040.0%0.00%
Q2 2022$92,000
-62.3%
81,604
+0.0%
0.00%
Q1 2022$244,000
+13.0%
81,5940.0%0.00%
Q4 2021$216,000
-27.0%
81,5940.0%0.00%
-100.0%
Q3 2021$296,000
-16.4%
81,5940.0%0.00%0.0%
Q2 2021$354,000
+26.9%
81,5940.0%0.00%0.0%
Q1 2021$279,000
-2.4%
81,5940.0%0.00%0.0%
Q4 2020$286,000
+45.9%
81,5940.0%0.00%
Q3 2020$196,000
+31.5%
81,5940.0%0.00%
Q2 2020$149,000
+17.3%
81,5940.0%0.00%
Q1 2020$127,000
-27.4%
81,594
-0.4%
0.00%
Q4 2019$175,000
+14.4%
81,9340.0%0.00%
Q3 2019$153,000
-28.5%
81,9340.0%0.00%
-100.0%
Q2 2019$214,000
+1.4%
81,9340.0%0.00%0.0%
Q1 2019$211,000
+12.2%
81,9340.0%0.00%0.0%
Q4 2018$188,000
-28.5%
81,9340.0%0.00%0.0%
Q3 2018$263,000
+13.4%
81,9340.0%0.00%0.0%
Q2 2018$232,000
-20.0%
81,9340.0%0.00%0.0%
Q1 2018$290,000
-8.8%
81,9340.0%0.00%0.0%
Q4 2017$318,000
+52.9%
81,9340.0%0.00%0.0%
Q3 2017$208,000
-7.1%
81,9340.0%0.00%0.0%
Q2 2017$224,000
-17.3%
81,9340.0%0.00%0.0%
Q1 2017$271,000
+39.0%
81,9340.0%0.00%0.0%
Q4 2016$195,000
-35.2%
81,9340.0%0.00%0.0%
Q3 2016$301,000
+64.5%
81,9340.0%0.00%0.0%
Q2 2016$183,000
+7.6%
81,9340.0%0.00%0.0%
Q1 2016$170,000
-31.5%
81,9340.0%0.00%0.0%
Q4 2015$248,000
+22.8%
81,9340.0%0.00%0.0%
Q3 2015$202,000
-23.2%
81,9340.0%0.00%0.0%
Q2 2015$263,000
-10.2%
81,9340.0%0.00%0.0%
Q1 2015$293,000
+57.5%
81,9340.0%0.00%0.0%
Q4 2014$186,000
+17.0%
81,9340.0%0.00%0.0%
Q3 2014$159,000
-46.5%
81,9340.0%0.00%0.0%
Q2 2014$297,000
-6.6%
81,9340.0%0.00%0.0%
Q1 2014$318,000
+35.9%
81,9340.0%0.00%0.0%
Q4 2013$234,000
-20.1%
81,9340.0%0.00%0.0%
Q3 2013$293,000
+6.9%
81,9340.0%0.00%0.0%
Q2 2013$274,00081,9340.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders